| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Feb―24 |
COVID-19 and Pulmonary Hypertension: An Interesting Dynamic |
Saam Foroshani, Michael Airo, Avi Levine, William H. Frishman, Wilbert S. Aronow, Gregg M. Lanier |
| 2 |
[GO] |
2024―Feb―09 |
Coronavirus Disease 2019 (COVID-19) in Heart Transplant Recipients and Anti-SARS-CoV-2 Monoclonal Antibodies: Experience, Lessons Learnt, and Future Challenges |
Rohan Kapur, Kenji Okumura, Suguru Ohira, Ameesh Isath, Aditya Gandhi, Marina Keller, et al. (+5) Rajat Nog, Alan Gass, David Spielvogel, Steven Lansman, Abhay Dhand |
| 3 |
[GO] |
2024―Jan―29 |
The Impact of Long COVID-19 on the Cardiovascular System |
Matthew W. McMaster, Subo Dey, Tzvi Fishkin, Andy Wang, William H. Frishman, Wilbert S. Aronow |
| 4 |
[GO] |
2024―Jan―03 |
Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Review of Clinical Manifestations, Cardiac Complications and Medical Management |
Maya Pandit, William H. Frishman |
| 5 |
[GO] |
2023―Sep―07 |
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2, Part 10: Summing Up |
William H. Frishman |
| 6 |
[GO] |
2023―Aug―21 |
COVID-19 Associated Myocarditis: Prevalence, Pathophysiology, Diagnosis, and Management |
Ji Yan, Jiang Hong |
| 7 |
[GO] |
2023―Jul―03 |
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2, Part 9: The Worst Is Over? |
William H. Frishman |
| 8 |
[GO] |
2023―Apr―18 |
Cardiovascular Manifestations of the Long COVID Syndrome |
Marta Lorente-Ros, Subrat Das, Joseph Elias, William H. Frishman, Wilbert S. Aronow |
| 9 |
[GO] |
2023―Mrz―13 |
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2, Part 8 |
William H. Frishman |
| 10 |
[GO] |
2023―Feb―02 |
Cardiac Manifestations of Viral Infections, Including COVID-19 |
Hillary Weisleder, Eliana Jacobson, William H Frishman, Abhay Dhand |
| 11 |
[GO] |
2023―Feb―02 |
Postural Tachycardia Syndrome and COVID-19: Focus on Ivabradine Therapy |
Keshav Dixit, William H. Frishman |
| 12 |
[GO] |
2023―Feb―02 |
Cardiovascular Manifestations of Long COVID |
Ethan Krug, Keara C. Geckeler, William H. Frishman |
| 13 |
[GO] |
2022―Dez―28 |
Significant Mortality Associated With COVID-19 and Comorbid Cerebrovascular Disease |
Tolga Sursal, Chirag D. Gandhi, Kevin Clare, Eric Feldstein, Ilya Frid, Martin Kefina, et al. (+17) Daniela Galluzzo, Haris Kamal, Rolla Nuoman, Krishna Amuluru, Carrie R. Muh, Jared M. Pisapia, Edwin Gulko, Philip Overby, Dipak Chandy, Mill Etienne, Christeena Kurian, Gurmeen Kaur, Katarina Dakay, May AlHamid, Hosam Al-Jehani, Stephan A. Mayer, Fawaz Al-Mufti |
| 14 |
[GO] |
2022―Jun―09 |
Coronavirus disease 2019 (COVID-19) and Heart Transplantation: Single Center Experience and Review of the Literature |
Daniel Greenberg, Bo Li, Kenji Okumura, Christopher Nabors, Abhay Dhand |
| 15 |
[GO] |
2022―Mai―16 |
Mild to Moderate COVID-19 Infection and Myocarditis: A Review |
Eric Bailey, William H. Frishman |
| 16 |
[GO] |
2022―Mai―16 |
Cardiovascular and Hematologic Complications of COVID-19 Vaccines |
Jordana Herblum, William Frishman |
| 17 |
[GO] |
2022―Mrz―15 |
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus 2, Part 7. COVID-19, What Next? |
William H. Frishman |
| 18 |
[GO] |
2021―Okt―25 |
Cardiopulmonary Phenotypes of Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 |
Muhammad H. Khan, Richard C. Becker |
| 19 |
[GO] |
2021―Okt―25 |
Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments |
Francine K. Welty, Nazanin Rajai, Maral Amangurbanova |
| 20 |
[GO] |
2021―Jul―22 |
Extracorporeal Membrane Oxygenation in Patients with COVID-19 |
Jayakumar Sreenivasan, Sagar Ranka, Shubham Lahan, Ahmed Abu-Haniyeh, Heyi Li, Risheek Kaul, et al. (+4) Aaqib Malik, Wilbert S. Aronow, William H. Frishman, Steven Lansman |
| 21 |
[GO] |
2021―Jul―22 |
Implications of Frailty in COVID-19 |
Curtis Lee, William H. Frishman |
| 22 |
[GO] |
2021―Jul―15 |
Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease 2019 |
Tzvi Fishkin, Michael D. Goldberg, William H. Frishman |
| 23 |
[GO] |
2021―Jul―15 |
Arrhythmogenesis and COVID-19 |
John N. Varkey, William H. Frishman |
| 24 |
[GO] |
2021―Jul―05 |
COVID-19 and Cardiometabolic Disease |
Chan W. Kim, Wilbert S. Aronow, William H. Frishman |
| 25 |
[GO] |
2021―Mrz―24 |
CARDIOVASCULAR AND CEREBROVASCULAR COMPLICATIONS WITH COVID-19 |
Arielle Greenberg, Gayatri Pemmasani, Srikanth Yandrapalli, William H. Frishman |
| 26 |
[GO] |
2020―Dez―03 |
Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019: Erratum |
|
| 27 |
[GO] |
2020―Nov―02 |
Characteristics and Outcomes of Patients 80 Years and Older Hospitalized with Coronavirus Disease 2019 (COVID-19) |
Christopher Nabors, Abhinaya Sridhar, Urvashi Hooda, Stephen A. Lobo, Avi Levine, William H. Frishman, Abhay Dhand |
| 28 |
[GO] |
2020―Sep―18 |
Thrombotic Complications of COVID-19 Infection |
Rebecca Castro, William H. Frishman |
| 29 |
[GO] |
2020―Sep―18 |
The 11th Trial of a Cardiovascular Clinical Trialist - Coronavirus-2, Part 3 |
William H. Frishman |
| 30 |
[GO] |
2020―Sep―16 |
Myocarditis in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) |
Supriya Jain, Sheila M. Nolan, Aalok R. Singh, Leif Lovig, Rachel Biller, Aditi Kamat, et al. (+5) Mary H. Brennan, Markus Erb, Erin Rescoe, Gary Tatz, Michael H. Gewitz |
| 31 |
[GO] |
2020―Sep―16 |
The Use of Non-Steroidal Anti-inflammatory Drugs for Coronavirus Disease 2019 |
Daniel Zhao, Sandy Zhang, Teryn Igawa, William Frishman |
| 32 |
[GO] |
2020―Aug―10 |
A Review of Remdesivir for COVID-19 |
Monica Mehta, Grace Shyh |
| 33 |
[GO] |
2020―Aug―05 |
Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019 |
Lauren A. Schluenz, Gerardo P. Ramos-Otero, James J. Nawarskas |
| 34 |
[GO] |
2020―Jul―14 |
Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19 |
Siddharth Shah, Kuldeep Shah, Siddharth B Patel, Foram S Patel, Mohammed Osman, Poonam Velagapudi, et al. (+3) Mohit K. Turagam, Dhanunjaya Lakkireddy, Jalaj Garg |
| 35 |
[GO] |
2020―Jul―08 |
THE 11TH TRIAL OF A CARDIOVASCULAR CLINICAL TRIALIST CORONAVIRUS-2 |
William H. Frishman |
| 36 |
[GO] |
2020―Mai―19 |
ACE Inhibitors and ARBs in Patients with COVID-19 |
Grace I. Shyh, James J. Nawarskas, Angela Cheng-Lai |
| 37 |
[GO] |
2020―Mai―19 |
COVID-19 and Its Impact on Cardiovascular Disease |
Iva Golemi Minga, Lolita Golemi, Alfonso Tafur, Amit Pursnani |
| 38 |
[GO] |
2020―Mai―19 |
THE 11TH TRIAL OF A CARDIOVASCULAR CLINICAL TRIALIST -CORONAVIRUS-2 (SARS-CoV2) |
William H. Frishman |
